FMAGX
Price
$13.42
Change
-$0.06 (-0.45%)
Updated
Apr 17 closing price
Net Assets
33.58B
VIGRX
Price
$181.21
Change
+$0.19 (+0.10%)
Updated
Apr 17 closing price
Net Assets
260.76B
Ad is loading...

FMAGX vs VIGRX

Header iconFMAGX vs VIGRX Comparison
Open Charts FMAGX vs VIGRXBanner chart's image
Fidelity Magellan
Price$13.42
Change-$0.06 (-0.45%)
VolumeN/A
Net Assets33.58B
Vanguard Growth Index Investor
Price$181.21
Change+$0.19 (+0.10%)
VolumeN/A
Net Assets260.76B
FMAGX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FMAGX vs. VIGRX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMAGX is a Buy and VIGRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 261B vs. FMAGX (33.6B). VIGRX pays higher dividends than FMAGX: VIGRX (0.39) vs FMAGX (0.23). FMAGX was incepted earlier than VIGRX: FMAGX (62 years) vs VIGRX (32 years). FMAGX (0.47) is less costly to investors than VIGRX (0.17). FMAGX is a more actively managed with annual turnover of: 55.00 vs. VIGRX (5.00). FMAGX has a lower initial minimum investment than VIGRX: FMAGX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 6.01 vs. FMAGX (-2.10). VIGRX return over 5 years is better than : 99.21 vs. FMAGX (38.39).
FMAGXVIGRXFMAGX / VIGRX
Total Expense Ratio0.470.17276%
Annual Report Gross Expense Ratio0.470.17276%
Fund Existence62 years32 years-
Gain YTD-9.103-14.32664%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets33.6B261B13%
Annual Yield % from dividends0.230.3959%
Returns for 1 year-2.106.01-35%
Returns for 3 years5.5430.3318%
Returns for 5 years38.3999.2139%
Returns for 10 years41.02223.8418%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKT6.330.18
+2.93%
Rocket Pharmaceuticals
OVV33.820.72
+2.18%
Ovintiv
USAC25.220.29
+1.16%
USA Compression Partners LP
UNB31.340.35
+1.13%
Union Bankshares
VVOS2.100.02
+0.96%
Vivos Therapeutics